Meglumine

Meglumine

SCHEMBL4274398

CCO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TACR1TTRgyrAgyrBparCparE

The experimentally established mechanism targets of Meglumine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.91
LMNA P02545 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
TDP1 Q9NUW8 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.46
PDE4A P27815 1/20 0.38
USP2 O75604 1/20 0.35
SLCO1B1 Q9Y6L6 1/20 0.35
CYP1A2 P05177 1/20 0.33
TSHR P16473 1/20 0.33
HIF1A Q16665 1/20 0.33
TOP1 P11387 1/20 0.32
ALOX15 P16050 1/20 0.31
SLC6A2 P23975 2/20 0.30
SLC6A4 P31645 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Meglumine SCHEMBL12195402 0.95 KDM4E (1.00) KDM4ELMNAL3MBTL1TDP1SMN1; SMN2
Meglumine SCHEMBL18270062 0.95 KDM4E (1.00) KDM4ELMNAL3MBTL1TDP1SMN1; SMN2
Meglumine SCHEMBL20836266 0.95 KDM4E (1.00) KDM4ELMNAL3MBTL1TDP1SMN1; SMN2
Meglumine SCHEMBL23363691 0.95 KDM4E (1.00) KDM4ELMNAL3MBTL1TDP1SMN1; SMN2
Meglumine SCHEMBL724392 0.95 KDM4E (1.00) KDM4ELMNAL3MBTL1TDP1SMN1; SMN2
Meglumine SCHEMBL23106596 0.95 KDM4E (1.00) KDM4ELMNAL3MBTL1TDP1SMN1; SMN2
Meglumine SCHEMBL22641548 0.95 KDM4E (1.00) KDM4ELMNAL3MBTL1TDP1SMN1; SMN2
Meglumine SCHEMBL23363692 0.95 KDM4E (1.00) KDM4ELMNAL3MBTL1TDP1SMN1; SMN2
Meglumine SCHEMBL22562873 0.95 KDM4E (1.00) KDM4ELMNAL3MBTL1TDP1SMN1; SMN2
Meglumine SCHEMBL14126374 0.95 KDM4E (1.00) KDM4ELMNAL3MBTL1TDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2068956-B1 MEDICAL DEVICES FOR RELEASE OF LOW SOLUBILITY THERAPEUTIC AGENTS BOSTON SCIENT LTD (BM) 2017-03-01 EP disclosed
EP-2068956-A2 MEDICAL DEVICES FOR RELEASE OF LOW SOLUBILITY THERAPEUTIC AGENTS Boston Scientific Limited (BB) 2009-06-17 EP disclosed
WO-2008002434-A2 MEDICAL DEVICES FOR RELEASE OF LOW SOLUBILITY THERAPEUTIC AGENTS BOSTON SCIENTIFIC SCIMED, INC. (US) 2008-01-03 WO disclosed
US-20070298069-A1 Medical devices for release of low solubility therapeutic agents BOSTON SCIENTIFIC SCIMED, INC. 2007-12-27 US disclosed
US-5028625-A Chewable Tablet For Oral Administration AMERICAN HOME PRODUCTS CORPORATION (US) 1991-07-02 US disclosed